Skip Navigation

A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.

We deliver transformative solutions that power real results. See how we can help.

Optimizing Supply Chain
Integrating Pharmacy
Maximizing Value-Based Care
Awards and Recognition

Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.

Sustainability

Guided by our values, our employees work every day to make meaningful differences in healthcare. At the core of what we do is our most valuable resource - our people. Learn more about us.

Leadership
Board of Directors
Speakers Bureau

Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.

Collective purchasing power lowers costs across your organization.

Intelligence plus unparalleled analytics equals data-driven solutions.

It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.

Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.

A voice for better healthcare policy is a voice for you.

Working closely with our members, we’re developing products and services to solve your most complex challenges.

Lower costs, greater efficiencies and a healthier bottom line.

Proven practices that result in better outcomes.

Intersecting specialty drugs with better management and data-driven best practices.

Controlling your future with integrated care delivery practices.

More savings and ROI is a win-win.

Data diving to deliver insights you can act on.

Supporting healthcare transformation through the generation of real-world evidence.

Working closely with our members, we're developing products and services to solve your most complex challenges.

Discover what leading healthcare providers are achieving through Premier membership.

Stay informed with our white papers, webinars and e-books.

Browse our blog for a taste of what’s new and what’s next in healthcare.

Premier’s perspectives have been solicited by nationally renowned publications. Read on.

Read Premier’s latest announcements.

Catch our policy statements and perspectives on the latest in DC.

Compelling stories from the front lines of America’s health systems.

The proactive, predictive and behind-the-scenes insights you need to stay ahead in healthcare delivered monthly to your inbox.

Premier Recommends Steps to Curb Antimicrobial Resistance

Premier submitted a statement for the record for the House Energy and Commerce Oversight and Investigation Subcommittee hearing entitled, Antimicrobial Resistance: Examining an Emerging Public Health Threat. Premier has long recognized the critical need for antibiotic stewardship and is committed to reducing antimicrobial resistance, including through our own data-driven solutions, research and educational services, and performance improvement collaboratives. In our statement, we urged Congress to support these efforts by advancing policies to:

  • Harness the power of technology. Premier urged the committee to advance antimicrobial stewardship by incentivizing the adoption and utilization of AI-enabled technology in healthcare. Premier offered a case study evaluating the use of clinical surveillance technology to identify overuse of antibiotics and drug-bug mismatches, reduce time-to-appropriate therapy and enhance therapy for difficult-to-treat pathogens. We also urged Congress to designate funds to ensure nursing homes can implement electronic clinical surveillance technology that will provide meaningful assistance with infection control, improve quality and reduce costs.
  • Leverage collaborative models. Premier recommends that Congress support the development of a hospital collaborative to drive engagement, improvement and innovation in patient safety, including through advancing best practices in antimicrobial stewardship.
  • Ensure access to older generic antibiotics. Premier underscored the importance of ensuring older generic injectable antibiotics which have been on the FDA drug shortage list for years – such as penicillin, cefazolin, cefotaxime, and erythromycin – are available for patient use.
Login Register Change Registration